Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Lyshult Medical AB
AB
Active
Org 5568170277
Östra Kyviksvägen 23 B, 429 30
Kullavik
Medical specialists activities
· NACE 8622
Est. 2010
0 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Lyshult Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
80
128
96
0
88
Staff expenses
—
−9
−9
−0
−8
EBITDA
47
100
58
−20
64
Depreciation & amort.
−0
—
—
—
—
EBIT
47
100
58
−20
64
Net financials
—
0
0
1
1
Profit before tax
47
100
61
0
50
Tax
−10
−21
−13
—
−10
Net profit
37
79
48
0
40
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
304
282
260
153
234
Equity
233
212
200
140
180
Long-term debt
0
—
—
—
—
Short-term debt
48
47
40
12
38
Total debt
48
47
40
12
38
Financial ratios
5-year trend
EBITDA margin
73.0%
This company
15.8%
Market median
+362% vs market
2021
2025
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
2021
2025
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
2021
2025
Net profit margin
45.2%
This company
8.1%
Market median
+458% vs market
2021
2025
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
2021
2025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Lyshult Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network